Inventiva IVA
NASDAQ IVA
$4.78 -0.06 (-1.24%)
As of: Sep 4, 2026 · 3:59 PM EDT

Inventiva (IVA) Shares Outstanding (2019 - 2025)

Inventiva (IVA) posted quarterly Shares Outstanding (Entity) of $69186.0 for Q4 2025, up 15.74% year-over-year from $59779.0 in Q4 2024, and up 71.63% quarter-over-quarter from $40311.0 in Q2 2025.

Analysis

Inventiva (IVA) Shares Outstanding (2019 - 2025) Analysis & Trends

Inventiva's Shares Outstanding (Entity) history runs 8 years deep, the most recent figure standing at $69186.0 for Q4 2025.

  • In Q4 2025, Shares Outstanding (Entity) rose 15.74% year-over-year to $69186.0; the TTM figure through Dec 2025 stood at $69186.0 (up 15.74% YoY), while the FY2025 annual figure was $69186.0, up 15.74% from the prior year.
  • Shares Outstanding (Entity) for Q4 2025 stood at $69186.0, up from $40311.0 in the prior quarter.
  • The five-year high for Shares Outstanding (Entity) was $41.4 million in Q4 2022, with the low at $41.0 in Q2 2022.
  • The 5-year median for Shares Outstanding (Entity) is $55880.5 (2024), against an average of $12.0 million.
  • The sharpest annual moves came in 2022 and 2023: Shares Outstanding (Entity) tumbled 100.0% in 2022, then jumped 102448.78% in 2023.
  • Inventiva's Shares Outstanding (Entity) stood at $39.2 million in 2021, then gained by 5.83% to $41.4 million in 2022, then slumped by 99.91% to $37793.0 in 2023, then surged by 58.17% to $59779.0 in 2024, then gained by 15.74% to $69186.0 in 2025.
  • Business Quant data shows IVA's Shares Outstanding (Entity) at $69186.0 in Q4 2025, $40311.0 in Q2 2025, and $59779.0 in Q4 2024.
Peer Set

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr) Shares Outstanding (Qtr)
1 Vertex Pharmaceuticals 138.47 Bn 130.62 Bn 2.84 Bn 253.70 Mn
2 Regeneron Pharmaceuticals 85.18 Bn 77.19 Bn 3.93 Bn 102.80 Mn
3 Argenx Se 63.38 Bn 58.19 Bn 1.37 Bn 61.30 Mn
4 Moderna 58.09 Bn 52.95 Bn 52.00 Mn 398.00 Mn
5 Revolution Medicines 44.33 Bn 44.33 Bn - 210.89 Mn
6 BeOne Medicines 40.02 Bn 34.92 Bn 1.53 Bn 111.58 Mn
7 Alnylam Pharmaceuticals 35.57 Bn 32.27 Bn 992.69 Mn 133.61 Mn
8 Royalty Pharma 28.45 Bn 27.61 Bn - 445.06 Mn
9 Insmed 27.48 Bn 26.32 Bn 358.27 Mn 217.35 Mn
10 Inventiva 893.85 Mn 893.85 Mn - 186.80 Mn
Historic Data

Historic Data

Download Data
DateValue
Dec 31, 2025 186.80 Mn
Jun 30, 2025 59.78 Mn
Dec 31, 2024 59.78 Mn
Jun 30, 2024 45.35 Mn
Dec 31, 2023 45.35 Mn
Jun 30, 2023 41.45 Mn
Dec 31, 2022 41.45 Mn
Sep 22, 2022 39.17 Mn
Jun 30, 2022 39.17 Mn
Dec 31, 2021 39.17 Mn
Jun 30, 2021 33.87 Mn
Mar 31, 2021 33.87 Mn
Dec 31, 2020 33.87 Mn
Jun 30, 2020 23.52 Mn
Mar 31, 2020 23.52 Mn
Dec 31, 2019 23.52 Mn